01548 金斯瑞生物科技
按盘价 
10.760 -0.080 (-0.738%) | 2023/06 - 中期 美元() | 2022/06 美元() | 2021/06 美元() | 2020/06 美元() | 2019/06 美元() |
非流动资产
| 投资物业 | 6,185,000 | -- | 7,218,000 | 7,472,000 | 7,562,000 |
| 物业、厂房、设备及其他 | 565,229,000 | -- | 395,252,000 | 280,004,000 | 194,538,000 |
| 租賃土地 | 121,216,000 | -- | 41,741,000 | -- | 17,198,000 |
| 无形资产 | 25,118,000 | -- | 41,393,000 | 42,559,000 | 35,004,000 |
| 联营公司及共同控制公司权益 | 16,804,000 | -- | 3,319,000 | 2,504,000 | 2,985,000 |
| 其他非流动资产 | 181,417,000 | -- | 27,801,000 | 47,626,000 | 33,412,000 |
| 915,969,000 | -- | 516,724,000 | 380,165,000 | 290,699,000 |
流动资产
| 存货 | 51,515,000 | -- | 34,886,000 | 24,179,000 | 14,724,000 |
| 现金及银行结存 | 1,397,334,000 | -- | 957,615,000 | 706,693,000 | 283,579,000 |
| 其他流动资产 | 1,019,503,000 | -- | 378,838,000 | 328,771,000 | 292,950,000 |
| 持作出售资产 | 0 | -- | 0 | 0 | 0 |
| 2,468,352,000 | -- | 1,371,339,000 | 1,059,643,000 | 591,253,000 |
流动负债
| 其他流动负债 | 437,904,000 | -- | 421,285,000 | 278,686,000 | 163,535,000 |
| 持作出售资产相关负债 | 0 | -- | 0 | 0 | 0 |
| 437,904,000 | -- | 421,285,000 | 278,686,000 | 163,535,000 | |
| 流动资产净值 | 2,030,448,000 | -- | 950,054,000 | 780,957,000 | 427,718,000 |
| 资产总额减流动负债 | 2,946,417,000 | -- | 1,466,778,000 | 1,161,122,000 | 718,417,000 |
非流动负债
| 860,373,000 | -- | 307,425,000 | 275,671,000 | 259,418,000 |
资本及储备
| 股本 | 2,116,000 | -- | 2,081,000 | 1,918,000 | 1,860,000 |
| 储备 | 1,352,485,000 | -- | 1,008,797,000 | 941,443,000 | 452,041,000 |
| 其他 | 0 | -- | 0 | 0 | 0 |
| 股东资金 | 1,354,601,000 | -- | 1,010,878,000 | 943,361,000 | 453,901,000 |
| 非控股权益 | 731,443,000 | -- | 148,475,000 | (57,910,000) | 5,098,000 |
| 其他 | 0 | -- | 0 | 0 | 0 |
| 2,086,044,000 | -- | 1,159,353,000 | 885,451,000 | 458,999,000 |
承担及或然负债
| 承担 | -- | -- | -- | -- | -- |
| 或然负债 | -- | -- | -- | -- | -- |
| 备注： | 实时报价更新时间为25/04/2024 18:00 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) () | USD -95,477,000 |
| 增长率 | -57.912% |
| 每股盈利/(亏损) | USD -0.045 |
| 每股账面资产净值 ($) | USD 0.655 |